Paper3500513
Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene.
Velu TJ and 6 others. Science, 1987. Cited by 454 papers, by iCite.
Cite this record
ConductScience Library. Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. Papers, record 3500513. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3500513
- Cell line
- EGFR-T172 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Neoplastic | Major topic |
| Epidermal Growth Factor | Major topic |
| ErbB Receptors | Major topic |
| Proto-Oncogenes | Major topic |
| Animals | |
| Cells, Cultured | |
| DNA, Recombinant | |
| Fibroblasts | |
| Genetic Vectors | |
| Harvey murine sarcoma virus | |
| Humans | |
| Male | |
| Mice | |
| Mice, Nude | |
| Neoplasms, Experimental | |
| Proto-Oncogene Mas | |
| Recombinant Proteins |
Source PubMed
Cited by137
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 454 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38201528 | Progress in Glioma Stem Cell Research. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/38201528 | PubMed |
| 38073064 | SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma. | Mol Oncol | 2024 | https://conductscience.org/library/papers/38073064 | PubMed |
| 37768281 | Building a large gene expression-cancer knowledge base with limited human annotations. | Database (Oxford) | 2023 | https://conductscience.org/library/papers/37768281 | PubMed |
| 37446288 | An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37446288 | PubMed |
| 37425733 | SOS2 regulates the threshold of mutant EGFR-dependent oncogenesis. | bioRxiv | 2023 | https://conductscience.org/library/papers/37425733 | PubMed |
| 36125064 | EGFR, the Lazarus target for precision oncology in glioblastoma. | Neuro Oncol | 2022 | https://conductscience.org/library/papers/36125064 | PubMed |
| 35864539 | The mitochondrial unfolded protein response (UPRmt): shielding against toxicity to mitochondria in cancer. | J Hematol Oncol | 2022 | https://conductscience.org/library/papers/35864539 | PubMed |
| 35565451 | Muscarinic Receptors Associated with Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35565451 | PubMed |
| 31508364 | Rethink of EGFR in Cancer With Its Kinase Independent Function on Board. | Front Oncol | 2019 | https://conductscience.org/library/papers/31508364 | PubMed |
| 31430896 | EGFR-c-Src-Mediated HDAC3 Phosphorylation Exacerbates Invasion of Breast Cancer Cells. | Cells | 2019 | https://conductscience.org/library/papers/31430896 | PubMed |
| 30241301 | Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/30241301 | PubMed |
| 29662194 | An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo. | Oncogene | 2018 | https://conductscience.org/library/papers/29662194 | PubMed |
| 28874603 | Cancer-associated arginine-to-histidine mutations confer a gain in pH sensing to mutant proteins. | Sci Signal | 2017 | https://conductscience.org/library/papers/28874603 | PubMed |
| 28513565 | Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways. | Cancers (Basel) | 2017 | https://conductscience.org/library/papers/28513565 | PubMed |
| 26646697 | Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer. | Oncotarget | 2016 | https://conductscience.org/library/papers/26646697 | PubMed |
| 26630010 | Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26630010 | PubMed |
| 26182292 | P2Y2 Receptor and EGFR Cooperate to Promote Prostate Cancer Cell Invasion via ERK1/2 Pathway. | PLoS One | 2015 | https://conductscience.org/library/papers/26182292 | PubMed |
| 26004186 | The CREB Coactivator CRTC2 Is a Lymphoma Tumor Suppressor that Preserves Genome Integrity through Transcription of DNA Mismatch Repair Genes. | Cell Rep | 2015 | https://conductscience.org/library/papers/26004186 | PubMed |
| 25506469 | Molecular detection, phylogenetic analysis, and identification of transcription motifs in feline leukemia virus from naturally infected cats in malaysia. | Vet Med Int | 2014 | https://conductscience.org/library/papers/25506469 | PubMed |
| 25503978 | Constitutive and ligand-induced EGFR signalling triggers distinct and mutually exclusive downstream signalling networks. | Nat Commun | 2014 | https://conductscience.org/library/papers/25503978 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EGF | 1950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3500513
GET https://conductscience.org/api/papers/v1/3500513/cited_by?page=2